Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-18

FDA Approved: BROMFENAC — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original application for bromfenac from Aurobindo Pharma Limited, enabling a generic bromfenac product to enter the market. Bromfenac is an NSA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BROMFENAC (Bromfenac)

Snippet

ORIG AP for BROMFENAC (BROMFENAC)